open access
PET receptor imaging in clinical oncology
open access
Abstract
characterised by different metabolic processes and receptor
expression systems. These differences are known as cancer
phenotypes. Understanding these differences is the key to the
development of new diagnostic and therapeutic procedures.
Recent reports indicate that some tumour cells have increased
expression of receptors for somatostatin, bombesin, glucagon-
like peptide 1, substance P, vasoactive intestinal peptides,
or cholecystokinin.
Abstract
characterised by different metabolic processes and receptor
expression systems. These differences are known as cancer
phenotypes. Understanding these differences is the key to the
development of new diagnostic and therapeutic procedures.
Recent reports indicate that some tumour cells have increased
expression of receptors for somatostatin, bombesin, glucagon-
like peptide 1, substance P, vasoactive intestinal peptides,
or cholecystokinin.
Keywords
PET/CT, receptor imaging, somatostatin
Title
PET receptor imaging in clinical oncology
Journal
Issue
Pages
61-63
Published online
2013-02-19
Page views
520
Article views/downloads
1652
Keywords
PET/CT
receptor imaging
somatostatin
Authors
Jolanta Kunikowska
Leszek Królicki